1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Novacyt
  6. Company
    ALNOV   FR0010397232

NOVACYT

(ALNOV)
  Report
Real-time Euronext Paris  -  11:35 2022-08-17 am EDT
1.282 EUR   -5.53%
08/04Novacyt Launches First Fully Lyophilized Direct-to-PCR Assays; Shares Up 5%
MT
08/04Novacyt Announces the Launch of the First Fully Lyophilised (Freeze-Dried), Direct-To-PCR Assays
CI
07/28Novacyt Creates Research-use-only Adenovirus F41 Test Kit Amid Rising Hepatitis Cases
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsRevisions 
Business Summary
Logo Novacyt
Novacyt develops, produces, and sells in vitro and molecular diagnostic products for the microbiology, haematology and serology markets. The activity is organized around two sectors:

- development of solutions and diagnostic services. The group is also developing a manufacturing activity for reagents and kits for bacterial and blood tests;

- manufacture and sale of molecular screening kits (Primerdesign): for laboratories.
Sales per Business
20202021Delta
Primer Design306.8998.4%104.5593.8% -65.93%
IT-IS International7.772.5%10.799.7% +38.86%
Lab21 Products5.851.9%5.384.8% -8.13%
EUR in Million
Sales per region
20202021Delta
United Kingdom246.7979.1%49.7244.6% -79.85%
Europe (Excluding United Kingdom)36.0311.6%37.7933.9% +4.88%
Asia-Pacific7.512.4%11.059.9% +47.05%
America11.603.7%10.599.5% -8.72%
Africa3.431.1%1.471.3% -57.31%
Middle East6.462.1%0.840.7% -87.07%
EUR in Million
Managers
Name Title Age Since
David Allmond Chief Executive Officer & Director 51 2021
James Martin Mccarthy Chief Financial Officer & Director 55 -
Paul Oladimeji Group Head-Research & Development - 2016
Bryan Close Chief Operating Officer - 2022
Anthony Dyer Director & Chief Corporate Development Officer 49 2021
Guillermo Raimondo Chief Commercial Officer - 2021
Navin Nauth-Misir RA & QA Director - -
David Franks Chief Human Resources Officer - 2021
Members of the board
Name Title Age Since
James Christopher Wakefield Chairman 55 2014
Andrew John William Heath, Dr. Senior Independent Non-Executive Director 73 -
Edwin Snape, Dr. Independent Non-Executive Director 81 -
Juliet Thompson Independent Non-Executive Director 54 2017
Jean-Pierre Crinelli Non-Executive Director 71 2006
Anthony Dyer Director & Chief Corporate Development Officer 49 2021
James Martin Mccarthy Chief Financial Officer & Director 55 -
David Allmond Chief Executive Officer & Director 51 2021
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 70,626,248 66,929,113 94.8% 9,028 0.0% 94.8%
Shareholders
NameEquities%
Biosynex SA 2,855,959 4.04%
BlackRock Investment Management (UK) Ltd. 1,986,434 2.81%
Octopus Investments Ltd. 1,336,721 1.89%
J.O. Hambro Capital Management Ltd. 822,971 1.17%
BlackRock Fund Advisors 760,994 1.08%
American Century Investment Management, Inc. 284,100 0.40%
Ninety One UK Ltd. 214,382 0.30%
SSgA Funds Management, Inc. 194,111 0.27%
Goldman Sachs Asset Management LP 122,073 0.17%
BlackRock Advisors (UK) Ltd. 111,959 0.16%
Markets and indexes
- PEA / SRD eligible : YES / NO
- Euronext Growth Paris
- Euronext Growth All-Share / CAC PME, EnterNext© PEA-PME 150, OSEO Innovation, PEA, PEA-PME
Stock Exchange Codes
- Bloomberg Code :  
- Reuters Code :  ALNOV.PA
- Datastream Code :  
Company contact information
Novacyt
13 Avenue Morane Saulnier
FR-78140 Vélizy-Villacoublay

Phone : +33 (0)1 39 46 51 04
Fax : +33 (0)1 30 70 05 32
web site : http://www.novacyt.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Novacyt
Sector Biotechnology & Medical Research
1st jan.Capi. (M$)
NOVACYT-69.03%97
GILEAD SCIENCES, INC.-8.65%82 985
VERTEX PHARMACEUTICALS37.98%78 356
MODERNA, INC.-33.87%69 156
REGENERON PHARMACEUTICALS, INC.2.72%68 773
IQVIA HOLDINGS INC.-13.27%46 302
LONZA GROUP AG-25.21%44 721
WUXI APPTEC CO., LTD.-23.26%40 492
BIONTECH SE-37.79%39 486
SEAGEN INC.10.30%31 083
ALNYLAM PHARMACEUTICALS, INC.34.54%27 727
GENMAB A/S2.36%24 079
CELLTRION, INC.6.57%21 868
ARGENX SE18.24%21 041
BEIGENE, LTD.-30.52%20 400
ICON PUBLIC LIMITED COMPANY-20.47%20 178
BIO-TECHNE CORPORATION-28.47%14 833
HANGZHOU TIGERMED CONSULTING CO., LTD.-19.98%12 619
PHARMARON BEIJING CO., LTD.-20.24%12 519
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.-39.46%11 795
QIAGEN N.V.-12.23%11 307
Connections : Novacyt